Bactericidal activity of telavancin, vancomycin and metronidazole against Clostridium difficile

Anaerobe

Volumn 16, Issue 3, 2010, Pages 220-222

  Goldstein, Ellie J C ^a,b   Citron, Diane M ^a   Tyrrell, Kerin L ^a   Warren, Yumi A ^a  

^a R M ALDEN RESEARCH LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bactericidal activity; C. difficile; Metronidazole; Televancin; Vancomycin

Indexed keywords

METRONIDAZOLE; TELAVANCIN; VANCOMYCIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL SPORE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CLOSTRIDIUM DIFFICILE; CONCENTRATION RESPONSE; CONTROLLED STUDY; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; COMPARATIVE STUDY; DRUG EFFECTS; HUMAN; MICROBIAL SENSITIVITY TEST; PEPTOCLOSTRIDIUM DIFFICILE; TIME;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; TIME FACTORS; VANCOMYCIN;

CLOSTRIDIUM DIFFICILE;

EID: 77953229863     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2009.12.002     Document Type: Article

References (10)

1. Al-Nassir W.N., Sethi A.K., Nerandzic M.M., Bobulsky G.S., Jump R.L., Donskey C.J. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin. Clin Infect Dis 2008, 47:56-62.
2. Zar F.A., Bakkanagari S.R., Moorthi K.M., Davis M.B. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007, 45:302-307.
3. Baines S.D., O'Connor R., Freeman J., et al. Emergence of reduced susceptibility to metronidazole in Clostridium difficile. J Antimicrob Chemother 2008, 62:1046-1052.
4. Higgins D.L., Chang R., Debabov D.V., et al. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2005, 49:1127-1134.
5. King A., Phillips I., Kaniga K. Comparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration-dependent anti-infective with multiple mechanisms of action against gram-positive bacteria. J Antimicrob Chemother 2004, 53:797-803.
6. Draghi D.C., Benton B.M., Krause K.M., Thornsberry C., Pillar C., Sahm D.F. Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States. Antimicrob Agents Chemother 2008, 52:2383-2388.
7. Goldstein E.J., Citron D.M., Merriam C.V., Warren Y.A., Tyrrell K.L., Fernandez H.T. In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp. Antimicrob Agents Chemother 2004, 48:2149-2152.
8. Clabots C.R., Johnson S., Bettin K.M., et al. Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J Clin Microbiol 1993, 31:1870-1875.
9. Clinical and Laboratory Standards Institute Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard-seventh edition 2007, CLSI document M11-A7, CLSI, Wayne, PA.
10. Pelaez T., Cercenado E., Alcala L., et al. Metronidazole resistance in Clostridium difficile is heterogeneous. J Clin Microbiol 2008, 46:3028-3032.